Micro-X Ltd (ASX: MX1) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Micro-X Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Micro-X Ltd (ASX: MX1)
Latest News
Small Cap Shares
Morgans names 2 small cap ASX shares to buy
Small Cap Shares
Morgans says these small cap ASX shares can rocket 50% to 100%+
Healthcare Shares
Guess which ASX medical tech share soared 37% at one point today
Broker Notes
Top brokers name 3 ASX small cap shares to buy
Broker Notes
Morgans picks small cap ASX shares with near-term share price catalysts
MX1 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Micro-X Ltd
Micro-X Ltd. manufactures, designs, and develops ultra-lightweight carbon nanotube based X-ray products for the global healthcare and explosive device markets. Its products include DRX Revolution Nano, Rover, Brain CT, and Mobile Backscatter Imaging. The company was founded by Peter Rowland on September 16, 2011 and is headquartered in Tonsley, Australia.
MX1 Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 14 Oct 2026 | $0.06 | $0.00 | 0.00% | 3,881,506 | $0.06 | $0.07 | $0.05 |
| 13 Oct 2026 | $0.06 | $0.00 | 0.00% | 891,084 | $0.06 | $0.06 | $0.06 |
| 12 Oct 2026 | $0.06 | $0.00 | 0.00% | 690,525 | $0.07 | $0.07 | $0.06 |
| 09 Oct 2026 | $0.06 | $0.01 | 18.52% | 9,775,957 | $0.06 | $0.08 | $0.05 |
| 08 Oct 2026 | $0.05 | $0.00 | 0.00% | 241,960 | $0.05 | $0.05 | $0.05 |
| 07 Oct 2026 | $0.05 | $0.00 | 0.00% | 345,657 | $0.05 | $0.05 | $0.05 |
| 06 Oct 2026 | $0.05 | $0.00 | 0.00% | 1,716,994 | $0.06 | $0.06 | $0.05 |
| 05 Oct 2026 | $0.06 | $-0.01 | -16.13% | 1,444,715 | $0.06 | $0.06 | $0.06 |
| 02 Oct 2026 | $0.06 | $0.00 | 0.00% | 1,616,079 | $0.06 | $0.07 | $0.06 |
| 01 Oct 2026 | $0.06 | $0.01 | 17.54% | 8,017,336 | $0.06 | $0.07 | $0.06 |
| 30 Sep 2026 | $0.06 | $0.01 | 20.41% | 18,027,612 | $0.05 | $0.09 | $0.05 |
| 29 Sep 2026 | $0.05 | $0.01 | 24.39% | 5,520,705 | $0.05 | $0.05 | $0.04 |
| 28 Sep 2026 | $0.04 | $0.00 | 0.00% | 2,031,650 | $0.05 | $0.05 | $0.04 |
| 25 Sep 2026 | $0.05 | $0.00 | 0.00% | 967,313 | $0.04 | $0.05 | $0.04 |
| 24 Sep 2026 | $0.04 | $-0.01 | -20.83% | 3,049,495 | $0.05 | $0.05 | $0.04 |
| 23 Sep 2026 | $0.05 | $0.02 | 66.67% | 4,751,168 | $0.03 | $0.05 | $0.03 |
| 22 Sep 2026 | $0.03 | $0.00 | 0.00% | 2,733,907 | $0.03 | $0.03 | $0.03 |
| 21 Sep 2026 | $0.03 | $0.01 | 55.56% | 1,104,026 | $0.02 | $0.03 | $0.02 |
| 18 Sep 2026 | $0.02 | $0.00 | 0.00% | 731,478 | $0.02 | $0.02 | $0.02 |
| 17 Sep 2026 | $0.02 | $0.00 | 0.00% | 4,345,202 | $0.02 | $0.02 | $0.02 |
| 16 Sep 2026 | $0.01 | $0.00 | 0.00% | 2,788,324 | $0.02 | $0.02 | $0.01 |
| 15 Sep 2026 | $0.02 | $0.00 | 0.00% | 3,043,936 | $0.02 | $0.02 | $0.02 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 09 Oct 2026 | Patrick O'Brien | Buy | 500,000 | $500,000 |
As advised by the company. Acquisition of Convertible Notes
|
| 09 Oct 2026 | James (Jim) McDowell | Buy | 500,000 | $500,000 |
As advised by the company. As per announcement, Acquisition of Convertible Notes
|
| 09 Oct 2026 | Ilona Meyer | Buy | 60,000 | $60,000 |
As advised by the company. Acquisition of Convertible Notes
|
| 09 Oct 2026 | Andrew Hartmann | Buy | 10,000 | $10,000 |
As advised by the company. Acquisition of Convertible Notes
|
| 22 Sep 2026 | Patrick O'Brien | Buy | 1,360,382 | $38,090 |
On-market trade.
|
| 24 Apr 2026 | Patrick O'Brien | Issued | 2,500,000 | $200,000 |
Placement.
|
| 13 Jan 2026 | Ilona Meyer | Expiry | 127,877 | $10,997 |
As advised by the company. Expiry of Performance Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Patrick Gerard O'Brien | Non-Executive DirectorNon-Executive Chairman | Aug 2015 |
Mr O'Brien has over 30 years business experience in Australia, the UK, Europe, Asia and the US including as a Senior Managing Director with Macquarie Group where he led teams in corporate finance (Melbourne 1996-2005) and private equity (London 2005-2009). He is also a Chairman/board member of a number of not-for-profit organisations and foundations. He is a member of the Risk and People Committee.
|
| Mr James (Jim) White McDowell | Non-Executive Director | Jan 2021 |
Mr McDowell has more than 30 years of senior leadership experience across the private and public sectors, with particular expertise in defence, aerospace, technology and government programs. He served as Deputy Secretary of the Naval Shipbuilding and Sustainment Group within the Australian Department of Defence. He was previously CEO of Nova Systems, Chief Executive of the South Australian Department of the Premier and Cabinet. He also held a number of non-executive and advisory roles, including Chair of the Australian Nuclear Science and Technology Organisation. He is a member of the Risk and People Committee.
|
| Ms Ilona Meyer | Non-Executive Director | Mar 2022 |
Ms Meyer has over 25 years of experience as a senior executive in healthcare, agriculture and emerging technologies focusing on innovation and growth. She is Vice President - Discover and General Counsel for Nuix Limited and prior to this role has held multiple executive roles with private and public companies, including ASX-listed companies and start-ups, leading business transformation initiatives, managing multiple stakeholders, influencing industry bodies. She is the chairperson of the Risk Committee.
|
| Mr Andrew Hartmann | Non-Executive Director | Dec 2022 |
Mr Hartmann has worked overseas and in global senior roles for more than 30 years. He has business expertise in the field of medical imaging devices with experience working in global roles with a focus on sales, marketing and business operations. He has held senior global management roles at Phillips, Carestream and Siemens, after working in Australia that included building brands across the Asia Pacific region, the United States and Europe.
|
| Mr Richard Walter Willson | Company Secretary | May 2025 |
-
|
| Dr Brian Gonzales | Chief Executive Officer | Aug 2026 |
-
|
| Peter Dickman | CFO |
-
|
|
| Brian Gonzales | Chief Executive Officer |
-
|
|
| Richard Walter Willson | Company Secretary |
-
|
|
| Anthony Skeats | COO |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 77,047,522 | 10.24% |
| Billion Prima SDN BHD | 64,166,667 | 8.53% |
| Varex Imaging Corporation | 54,130,053 | 7.20% |
| UBS Nominees Pty Ltd | 45,152,777 | 6.00% |
| Bindella Capital Pty Ltd (Stock Portfolio A/C) | 30,679,749 | 4.08% |
| Citicorp Nominees Pty Limited | 20,045,272 | 2.66% |
| BNP Paribas Nominees Pty Ltd (IB AU Noms Retail Client) | 19,641,268 | 2.61% |
| BNP Paribas Noms Pty Ltd | 17,390,944 | 2.31% |
| J P Morgan Nominees Australia Pty Limited | 15,475,738 | 2.06% |
| Mr Peter Robin Rowland | 14,194,697 | 1.89% |
| TLFTC Pty Ltd (The Lonsdale A/C) | 10,885,804 | 1.45% |
| Mr Mark Anthony McMahon | 8,993,136 | 1.20% |
| Dr Russell Kay Hancock | 5,500,000 | 0.73% |
| Mr David Leroy Boyles | 5,000,000 | 0.66% |
| Mrs Maria David | 4,966,867 | 0.66% |
| Harman Nominees Pty Ltd (Harmanis Investment A/C) | 4,816,556 | 0.64% |
| Kingsley Hall | 4,384,799 | 0.58% |
| Finclear Services Pty Ltd (Superhero Securities A/C) | 4,117,731 | 0.55% |
| Dr Aditya Agarwal | 3,904,120 | 0.52% |
| Code Nominees Pty Ltd (Retail A/C) | 3,701,046 | 0.49% |